quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 5, 2026

Stocks Pressured by Rising Oil Prices and Bond Yields

View original at nasdaq.com
Stocks Pressured by Rising Oil Prices and Bond Yields The S&P 500 Index ($SPX) (SPY) today is down -0.26%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.80%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.16%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Inflation is a bigger concern than economic growth as ECB assesses implications of war in Iran

    80% confidence
  • Astera Labs rated buy with $250 price target

    80% confidence
  • Real-time risk premium for crude oil at $18/barrel, corresponding to impact of six-week full halt to tanker traffic in Strait of Hormuz

    80% confidence
  • Broadcom expects its AI chip sales to top $100 billion next year

    80% confidence
  • Most of American Eagle Outfitters' profit will be generated in the second half of the year

    80% confidence
  • S&P earnings growth expected to climb by 8.4% in Q4, marking tenth consecutive quarter of year-over-year growth

    80% confidence
  • Prolonged conflict in Middle East would risk pushing inflation expectations higher

    80% confidence
  • Ships sailing through Strait of Hormuz could be at risk from missiles or rogue drones

    80% confidence
  • Fastenal February daily sales rate estimate of 7.2%

    80% confidence
  • Excluding Magnificent Seven megacap tech stocks, Q4 earnings expected to increase by 4.6%

    80% confidence
  • Four of six tanks at Saudi Arabia's Ras Tanura refinery were full, and Ju'aymah terminal is quickly running out of spare capacity

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stocks Pressured by Rising Oil Prices and Bond Yields — Source | Via News | pt.VIA.NEWS